CareFusion said Monday it acquired exclusive U.S. rights to sell Healthpoint's surgical hand scrubs, as it moves to expand its skin antisepsis portfolio.

The license agreement with Fort Worth, Texas-based Healthpoint gives CareFusion the exclusive right to sell products such as Surgicept waterless surgical hand scrub and Triseptin water-aided surgical scrub in the U.S.

San Diego, Calif.-based CareFusion's infection prevention portfolio already includes ChloraPrep, a patient perioperative skin antiseptic.

"With ChloraPrep for patient skin and Surgicept for the hands of surgical health care workers, we now offer a comprehensive line of clinically proven products to help reduce the risk of HAIs at their source: the skin," Jason Strohm, vice president and general manager of CareFusion Infection Prevention, said in a statement.

Healthpoint bought Surgicept, a product developed by a research scientist with Columbia University Medical Center in New York, in 2005.

"When we introduced Surgicept more than four years ago, we knew we had an excellent product that met clinicians' needs," Travis Baugh, the company's president and COO, said in a statement.

CareFusion's stock dipped one percent to reach $24.69 in recent trading Monday.

More Voices